Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Completed 21Unknown 15Recruiting 13Withdrawn 9Terminated 9Not yet recruiting 3Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Non-Small-Cell Lung 5Neoplasms 3Lung Neoplasms 3Carcinoma, Hepatocellular 3Brain Neoplasms 3Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Neoplasm Metastasis 2Colorectal Neoplasms 2Breast Neoplasms 2Stomach Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1Neoplasms, Second Primary 1NSCLC 1Lung Metastases 1Locally Advanced Pancreatic Cancer 1Kidney Neoplasms 1Hematologic Neoplasms 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Carcinoma, Pancreatic Ductal 1Cancer Pain 1CRC 1Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

lenvatinib 16Bevacizumab 14sintilimab 10tislelizumab 9apatinib 9regorafenib 6camrelizumab 6donafenib 5atezolizumab 5Immune Checkpoint Inhibitors 4Hepatectomy 4cabozantinib 3Radiosurgery 3Capecitabine 3spartalizumab 2pembrolizumab 2durvalumab 2anlotinib 2Surgical Procedures, Operative 2Specimen Handling 2Oxaliplatin 2Observation 2Magnetic Resonance Spectroscopy 2Injections 2Immunotherapy 2Folfox protocol 2Fecal Microbiota Transplantation 2Electroporation 2Blood Specimen Collection 2ursodoxicoltaurine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Hepatocellular × Radiosurgery × Clear all
NCT07381660 2026-02-02

SBRT Versus Surgical Resection for Small HCC

Sun Yat-sen University

Phase 3 Not yet recruiting
312 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06592612 2024-09-19

Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment

Sun Yat-sen University

Phase 2 Not yet recruiting
70 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05602974 2023-02-17

Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Not yet recruiting
140 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡